DRUG APPROVALS

May 17, 2019

Acute Myeloid Leukemia: From Molecular Pathogenesis to Oral Targeted Therapies

The frequent occurrence of mutations and gene alterations has spurred the development of novel agents for the treatment of AML, including new oral targeted therapies that have recently received regulatory approval.
October 16, 2018

Review of Selected NMEs 2018

October 16, 2018

New Drug Review 2018

October 13, 2017

New Drug Review 2017

October 13, 2017

Review of Selected NMEs 2017

October 14, 2016

Review of Selected NMEs 2016

October 14, 2016

New Drug Review 2016

October 16, 2015

New Drug Review 2015

October 16, 2015

Review of Selected NMEs 2015

October 16, 2014

New Drug Review 2014

October 16, 2014

Review of Selected NMEs 2014

October 18, 2013

New Drug Review 2013

October 18, 2013

Review of Selected NMEs 2013